SANJIVANI PARANTERAL

BSE: 531569 29 Jul 2025

Healthcare

₹ 222.8

Sanjivani Paranteral Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SANJIVANI PARANTERAL

BSE: 531569 29 Jul 2025

Healthcare

₹ 222.8

Sanjivani Paranteral Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

32.0

Dividend Yield

0.0%

Debt to Equity

0.21

Stock P/E

33.5

Market Cap

271.0 Cr

SANJIVANI PARANTERAL - Share Price & Details

Market Cap

₹271.0

High /Low

397.0 / 205.0

Stock P/E

33.5

Book Value

₹32.0

Dividend Yield

0.0

ROCE

28.5

ROE

₹24.6

Face Value

10.0

PEG Ratio

EVEBITDA

₹24.0

Debt

8.14

CMP / FCF

Debt to equity

₹0.21

NP Ann

8.09

High price all time

397.0

Piotroski score

₹3.0

Graham Number

70.0

No. Eq. Shares

1.21

Net CF

₹0.94

Net profit

8.09

Price to book value

7.03

Interest Coverage

₹18.5

Low price all time

3.17

Industry PE

34.0

Reserves

₹26.1

Free Cash Flow

₹-18.0

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.46	91.0
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
SANJIVANI PARANTERAL LTD.	186.08	21.94	181.81	1.62	271.0	33.5
ASARFI HOSPITAL LIMITED	NA	NA	NA	NA	260	24.6
AMBALAL SARABHAI ENTERPRISES L	31.21	-49.65	17.30	-0.64	248	28.7

Peer Comparison Chart

About SANJIVANI PARANTERAL

Sanjivani Paranteral Ltd., with Security Code 531569, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Is LCCCU stock overvalued or undervalued - Capitalize on fast-moving stock trends

(28 Jul 2025)

【Market Focus】✌️ Get ahead of the market with live updates and strategic insights.

Is Sanjivani Paranteral Limited (531569) a Good Long Term Bet - Tremendous portfolio expansion

(25 Jul 2025)

Is Sanjivani Paranteral Limited (531569) a Good Long Term Bet ✌️【Stock Buzz】✌️ Access global financial data and expert market predictions...

Top Investment Strategies for Indian Stocks High Accuracy Stock Calls - Superior stock selection

(25 Jul 2025)

【Stock Observations】✌️ Access top-performing stocks with live data and trend analysis tools.

GIC Housing Finance Limited (GICHSGFIN) Sees Unusual Trading Volume - Tremendous return rates

(25 Jul 2025)

【Market Insights】✌️ Access expert advice and real-time stock data to boost your investment performance.

Sanjivani Paranteral Limited (531569)’s Trend in 2025 - Overwhelming profit margins

(24 Jul 2025)

Sanjivani Paranteral Limited (531569)'s Trend in 2025 ✌️【Investor Updates】✌️ Expert advice and stock trend predictions to guide your daily...

Is Sanjivani Paranteral Limited (531569) a Good Long Term Bet - Unprecedented profits

(23 Jul 2025)

Is Sanjivani Paranteral Limited (531569) a Good Long Term Bet ✌️【Growth Stocks】✌️ Our team has a proven track record of predicting...

Quarterly Table

Standalone Consolidated

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	9.1	8.1	12.6	14.0	15.0	12.9	16.4	18.1	17.3	18.2
Expenses	8.2	6.7	10.6	11.9	13.0	10.7	14.1	15.3	14.8	15.5
Operating Profit	0.9	1.4	2.0	2.1	2.0	2.2	2.3	2.9	2.6	2.7
OPM %	10.12%	17.56%	15.99%	15.1%	13.09%	16.78%	14.22%	15.74%	14.7%	14.67%
Other Income	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.4	0.3	0.4
Interest	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2
Depreciation	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.2
Profit before tax	1.0	1.0	1.8	2.0	1.9	1.9	2.3	2.9	2.5	2.7
Tax %	0%	-0.1%	-13.9%	-14.1%	-13.2%	-33.2%	-24.6%	-21.3%	-24.4%	-15%
Net Profit	1.0	1.0	1.6	1.7	1.7	1.3	1.7	2.3	1.9	2.2
EPS in Rs	0.95	1	1.55	1.71	1.65	1.08	1.47	1.96	1.62	0

Metrics	Sep 2024	Dec 2024	Mar 2025
Sales	18.1	17.3	18.2
Expenses	15.3	14.8	15.5
Operating Profit	2.9	2.6	2.7
OPM %	15.74%	14.7%	14.67%
Other Income	0.4	0.3	0.4
Interest	0.2	0.2	0.2
Depreciation	0.1	0.2	0.2
Profit before tax	2.9	2.5	2.7
Tax %	-21.3%	-24.4%	-15.1%
Net Profit	2.3	1.9	2.2
EPS in Rs	1.96	1.62	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	-9%
5 Years:	19%
3 Years:	33%
TTM:	30%

Compounded Profit Growth
10 Years:	15%
5 Years:	38%
3 Years:	63%
TTM:	21%

Stock Price CAGR
10 Years:	28%
5 Years:	105%
3 Years:	63%
1 Year:	19%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	28%
5 Years:	105%
3 Years:	63%
1 Year:	19%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

SANJIVANI PARANTERAL

SANJIVANI PARANTERAL

SANJIVANI PARANTERAL - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About SANJIVANI PARANTERAL

Latest News

Is LCCCU stock overvalued or undervalued - Capitalize on fast-moving stock trends

Is Sanjivani Paranteral Limited (531569) a Good Long Term Bet - Tremendous portfolio expansion

Top Investment Strategies for Indian Stocks High Accuracy Stock Calls - Superior stock selection

GIC Housing Finance Limited (GICHSGFIN) Sees Unusual Trading Volume - Tremendous return rates

Sanjivani Paranteral Limited (531569)’s Trend in 2025 - Overwhelming profit margins

Is Sanjivani Paranteral Limited (531569) a Good Long Term Bet - Unprecedented profits

What analysts say about SLNHP stock - Game-changing returns

Sanjivani Paranteral Limited (531569) vs yyy - Massive profits

Sanjivani Paranteral Limited (531569) Stock Rallies - Accelerated capital growth

What drives GAIA stock price - Superior risk-adjusted returns

Best Stocks for a Post COVID Recovery in India Expert Financial Guidance - High-margin investment plays

AI Quality Stocks Best Stocks For Growth - Consistent triple-digit returns

Share Market Today | Latest Stock Market News, Sensex Today and Nifty Live Updates

Why is Sanjiv.Parant. falling/rising?

Sanjivani Paranteral standalone net profit rises 73.81% in the March 2025 quarter

Sanjivani Paranteral Reports Strong Financial Growth and Sales Surge in May 2025 Results

Sanjivani Parenteral Adjusts Valuation Grade Amid Competitive Industry Landscape

Sanjivani Paranteral Reports Strong Growth Amid Valuation Concerns and Debt Challenges

Sanjivani Paranteral consolidated net profit rises 73.81% in the March 2025 quarter

Sanjivani Paranteral posts Q4 FY25 at Rs. 2.19 Cr

Sanjivani Paranteral Limited Recommends Dividend for the First Time

Ashish Kacholia’s Portfolio: ‘Big Whale’ trimmed stake in this office space company, 5 others

Sanjivani Paranteral Ltd Experiences Notable Gains Amid Increased Buying Activity

Sanjivani Paranteral Shows Stability Amid Promising Long-Term Growth Prospects

Quarterly Results Today: Varun Beverages, Nykaa, Grasim Industries Among 290+ Companies To Declare Earnings

Sanjivani Paranteral Stock Reaches 52-Week High, Up 127.86% Over Past Year

Sanjivani Paranteral Reaches All-Time High Stock Price, Trading Near 52-Week Peak

Sanjivani Paranteral Achieves All-Time High Stock Price of Rs. 387.4

Sanjivani Paranteral Reaches All-Time High Stock Price, Surges 132.67% Over Past Year

Sanjivani Paranteral Stock Reaches 52-Week High of Rs. 386 on December 24, 2024

Sanjivani Paranteral Achieves All-Time High Amid Strong Market Performance

Sanjivani Paranteral Achieves 52-Week High of Rs. 368 on December 23, 2024

Sanjivani Paranteral Achieves 52-Week High Amid Strong Market Performance

Sanjivani Paranteral Experiences Revision in Its Stock Evaluation Amid Record High Performance

Kerala govt bans distribution and sale of certain medicines | Check full list here

Sanjivani Paranteral Reports Positive Q2 Results, Net Sales and Profitability on the Rise

Bharti Airtel, Adani Power, BHEL, Ambuja Cements, Sun Pharma, IGL, Pfizer, Indian Oil Q2 Results Today

Ashsih Kacholia picks up stake in this multibagger stock Walchandnagar Industries during Q4FY24

Sanjivani Paranteral Ltd Surges in Stock Market, Outperforms Sector by 1.85%

Sanjivani Paranteral Ltd's Stock Reaches All-Time High, Outperforms Sector by 0.68%

Sanjivani Paranteral Ltd's Stock Reaches All-Time High, Receives 'Buy' Call from MarketsMOJO

Sanjivani Paranteral Ltd Surges in Stock Market, Outperforms Sector and Sensex

Sanjivani Paranteral Ltd's Stock Reaches 52-Week High, Outperforms Sector by 1.47%

Sanjivani Paranteral Ltd's Stock Reaches All-Time High, Outperforms Sector by 2%

Sanjivani Paranteral Standalone June 2024 Net Sales at Rs 16.44 crore, up 30.65% Y-o-Y

Sanjivani Paranteral standalone net profit rises 10.32% in the June 2024 quarter

Sanjivani Paranteral Ltd's Stock Reaches 52-Week High, Outperforms Sector by 1.18%

Sanjivani Paranteral Ltd's Stock Reaches All-Time High, Outperforms Sector by 4.57%

Sanjivani Paranteral Ltd's Stock Hits 52-Week High, Outperforms Sector and Market.

Budget 2024: ‘Low-interest rates and grants should be included for boosting domestic API manufacturers’

Pharmaceutical logistics landscape of India

Pre-Budget 2024: Pharma sector urges government to boost R&D, Infrastructure development and policy support

Sanjivani Paranteral Share Price Today - Live Sanjivani Paranteral Ltd. Share Price and Stock Updates on NSE/BSE

Pharma stocks in which Ashish Kacholia and Mukul Agrawal bought stake in March Qtr; Do you own any?

This Multibagger Pharma Stock Gives 265% Return In One Year

Sanjivani Paranteral Ltd's Stock Hits 52-Week High, Reflecting Strong Growth Potential

दनादन रिटर्न दे रहा है यह शेयर, 12 महीनों में 250 फीसदी बढ़ा दाम, आशीष कचौलिया ने भी लगाया है पैसा

Ashish Kacholia Portfolio: Veteran investor buys stake in this microcap pharma stock

Ashish Kacholia portfolio: 'Big Whale' raises stake in multibagger stock that has surged 280% in one year | Stock Market News

Ashish Kacholia portfolio: Multibagger stock jumped 300% in 1 year

Ashish Kacholia portfolio: ’Big Whale’ raises stake in multibagger stock that has surged 280% in one year

Ashish Kacholia portfolio: 'Big Whale' raises stake in multibagger stock that has surged 280% in one year

Sanjivani Ltd hits upper circuit after Ashish Kacholia buys stake | To read full story | Inshorts

Sanjivani Paranteral Share Price

"We witness surplus of IV solutions and devices in north India, hardly any in south India"

Sanjivani Paranteral Ltd's Stock Reaches All-Time High

Sanjivani Paranteral Ltd forms subsidiary SPL Infusion Pvt Ltd

Sanjivani Paranteral Secures Major Investment

Sanjivani Paranteral Limited Secures Rs 30.88 Crore via Warrant Issuance and Preferential Allotment

Pharma stock hits upper circuit after Ashish Kacholia buys stake in the company

Sanjivani Paranteral Limited Secures Rs 30.88 Crore via Warrant Issuance and Preferential Allotment |